Archives

I’d like to share an important update on the Alzheimer’s drug, Aducanumab, marketed as Aduhelm in the US. Aduhelm is a monoclonal antibody drug which means that it mimics our own antibodies to [...]

By Dharma Singh Khalsa, MD For the first time in over 20 years, the U.S. FDA recently approved a new drug, aducanumab, for Alzheimer’s disease, which afflicts an estimated 6 million Americans. We [...]